InvestorsHub Logo

Number sleven

09/18/20 8:20 PM

#300046 RE: Triple88 #300043

Triple88, No problem. We need to assume at this point that a large portion of the US market will be lost. I for one still believe in our drug. The EU market is valuable. The untapped remainder of the world is also valuable. Unless JT is the moron some think he is. This company lacks the recourses to capture the market beyond the US. We only have one product. The only way I see this story playing out is with an EU approval followed by the sale of the company. I think a reasonable valuation is between $15 and $35. The US is not the only place where people die from cvd.
Sleven,